X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.nasdaq.com/articles/u.s.-fda-staff-flags-no-new-safety-concerns-for-biogens-als-drug-0
https://www.contractpharma.com/contents/view_breaking-news/2023-01-05/aurisco-to-build-oligonucleotides-manufacturing-facility-in-china/9769
https://www.businesswire.com/news/home/20221031005439/en/EUROAPI-to-Reach-500-kg-Peptide-and-Oligonucleotide-Capacity-Per-Year-in-Frankfurt-by-2025
https://www.expresspharma.in/promising-mnd-drug-helps-slow-disease-progression-and-benefits-patients-physically/
https://www.bachem.com/news/cell-penetrating-peptides-a-delivery-system-for-oligonucleotides/
https://www.ema.europa.eu/en/news/european-commission-ema-fda-agree-new-priorities-strengthen-their-collaboration-medicines
https://www.moneycab.com/interviews/thomas-meier-ceo-bachem-im-interview/
https://cen.acs.org/pharmaceuticals/Stanley-Crooke-finally-making-sense/97/i18
https://www.prnewswire.com/news-releases/genedesign-joins-ajinomoto-bio-pharma-services-and-opens-oligonucleotide-api-development-center-300822484.html
Market Place
Share 
